Differential anti-proliferative actions of peroxisome proliferator-activated receptor-γ agonists in MCF-7 breast cancer cells
Authors:
- Sung Soo KimSKSung Soo Kim
- Hyae Gyeong CheonHCHyae Gyeong Cheon
- 1 August 2006
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 72 (5) , 530-540
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Dual Neuroprotective Signaling Mediated by Downregulating Two Distinct Phosphatase Activities of PTENJournal of Neuroscience, 2004
- Suppression of prostaglandin E2 receptor subtype EP2 by PPARγ ligands inhibits human lung carcinoma cell growthBiochemical and Biophysical Research Communications, 2004
- Dose‐dependent suppression of hyperlipidemia and intestinal polyp formation in Min mice by pioglitazone, a PPARγ ligandCancer Science, 2003
- Peroxisome proliferator-activated receptor-γ upregulates caveolin-1 and caveolin-2 expression in human carcinoma cellsOncogene, 2003
- Peroxisome Proliferator-Activated Receptor γ Ligands Increase Release of Nitric Oxide From Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Akt Down-regulation of p38 Signaling Provides a Novel Mechanism of Vascular Endothelial Growth Factor-mediated Cytoprotection in Endothelial CellsJournal of Biological Chemistry, 2001
- Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTENCell, 1998
- Terminal Differentiation of Human Breast Cancer through PPARγMolecular Cell, 1998
- Ras may mediate mammary cancer promotion by high fatNutrition and Cancer, 1995
- mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.Genes & Development, 1994